IRIS PubliCatt

Marrocco, Ilaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 114
AS - Asia 80
NA - Nord America 64
Totale 258
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 62
IE - Irlanda 37
IT - Italia 34
CN - Cina 32
SG - Singapore 23
IN - India 22
RU - Federazione Russa 15
SE - Svezia 13
DE - Germania 8
CZ - Repubblica Ceca 3
CA - Canada 2
GB - Regno Unito 2
TW - Taiwan 2
AT - Austria 1
FI - Finlandia 1
PK - Pakistan 1
Totale 258
Salva come PNG Salva come JPEG
Città #
Ashburn 50
Dublin 37
Pune 21
Singapore 18
Milan 13
Moscow 13
Rome 9
New York 6
Halle 4
Brno 3
Busto Arsizio 3
Beijing 2
Brescia 2
Edmonton 2
Erba 2
Frankfurt am Main 2
Nuremberg 2
Tainan City 2
Vercelli 2
Chiswick 1
Forest City 1
Lappeenranta 1
London 1
Los Angeles 1
San Antonio 1
Sandston 1
Seattle 1
Vienna 1
Totale 202
Salva come PNG Salva come JPEG
Nome #
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 23
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activity 18
ERp57 chaperon protein protects neuronal cells from Aβ-induced toxicity 18
A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways 15
Shmt2: A Stat3 signaling new player in prostate cancer energy metabolism 15
Increased intake of energy-dense diet and negative energy balance in a mouse model of chronic psychosocial defeat 13
Egfr in cancer: Signaling mechanisms, drugs and acquired resistance 13
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 13
An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation 12
Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors 12
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment 12
Roles for growth factors and mutations in metastatic dissemination 11
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 11
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 11
Clustering of IRE1α depends on sensing ER stress but not on its RNase activity 11
Cancer Immunotherapy: The Dawn of Antibody Cocktails 11
Targeting her3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation egfr kinase inhibitor 10
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans 10
TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis 10
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 10
Comparative analysis of the interaction between different flavonoids and PDIA3 8
Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score 8
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators 6
Totale 281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202345 0 0 0 0 0 0 0 0 25 16 4 0
2023/2024226 2 44 0 34 10 43 11 3 1 9 33 36
2024/202510 9 1 0 0 0 0 0 0 0 0 0 0
Totale 281